Overview:
- UK healthcare company BTG acquired Israeli cancer treatment business Galil Medical for $110 million.
- Listed in New York and London, BTG focuses also focuses on cancer treatments.
- Galil has developed cryotherapy (compressed, cooled gas) treatments to reduce tumors, a less invasive process than chemotherapy or radiation.
- BTG paid an initial cash fee of $84.5 million for Galil, and will pay up to $100 million depending on the businesses performance before the end of 2018.
- BTG funded the acquisition through its cash reserves.
Ben Naylor - Regional editor